Online citations, reference lists, and bibliographies.
← Back to Search

Pathology Of Breast Cancer: From Classic Concepts To Molecular Pathology And Pathogenesis

Ilze Štrumfa, A. Vanags, A. Āboliņš, J. Gardovskis
Published 2012 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Summary Breast cancer has high incidence and still significant mortality. Due to the widespread application and efficacy of surgery in breast cancer treatment, the surgeon has a crucial role in the treatment planning. Taking into account the tendency to personalized cancer care and the heterogeneity of breast cancer, the surgeon has to be aware about the prognostic and predictive characteristics of breast cancer. We discuss here the classaic pathology of breast cancer along with molecular subtypes, novel prognostic markers and molecular pathogenesis.
This paper references
10.1126/SCIENCE.959840
The clonal evolution of tumor cell populations.
P. Nowell (1976)
10.1186/bcr2912
The microenvironment in breast cancer progression: biology and implications for treatment
A. Place (2011)
Expression of vascular endothelial growth factor in synovial fibroblasts is induced by hypoxia and interleukin 1beta.
J. Jackson (1997)
10.1371/journal.pone.0027339
Fascin Is a Key Regulator of Breast Cancer Invasion That Acts via the Modification of Metastasis-Associated Molecules
M. Al-Alwan (2011)
10.1002/cncr.23786
Reproductive and hormonal risk factors for postmenopausal luminal, HER‐2‐overexpressing, and triple‐negative breast cancer
A. Phipps (2008)
10.1073/pnas.191367098
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T. Sørlie (2001)
10.1001/JAMA.295.21.2492
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.
L. Carey (2006)
10.1186/1471-2407-11-348
MMP-1 expression has an independent prognostic value in breast cancer
Pia Boström (2011)
10.1387/ijdb.113365jt
Adipocyte is a non-trivial, dynamic partner of breast cancer cells.
J. Tan (2011)
10.1200/JCO.2008.18.1370
Supervised risk predictor of breast cancer based on intrinsic subtypes.
J. Parker (2009)
10.1634/theoncologist.2009-0078
Metastatic breast cancer: therapeutic options according to molecular subtypes and prior adjuvant therapy.
V. Guarneri (2009)
10.1080/00016340701444764
Connective tissue alterations in women with pelvic organ prolapse and urinary incontinence
Rafi Suzme (2007)
10.1002/(SICI)1096-9896(199912)189:4<521::AID-PATH472>3.0.CO;2-B
Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes
H. Buerger (1999)
10.1158/1078-0432.CCR-07-1127
Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution
D. Allred (2008)
10.1002/path.2808
The molecular pathology of breast cancer progression
A. Bombonati (2011)
10.1093/annonc/mdr304
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch (2011)
10.1186/bcr2925
Epigenetics in breast cancer: what's new?
Yi Huang (2011)
10.1371/journal.pone.0020297
The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
F. Reyal (2011)
10.1073/pnas.1018898108
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
D. Iliopoulos (2011)
10.1074/JBC.270.11.5872
Matrix Metalloproteinase-2 Is an Interstitial Collagenase
R. Aimes (1995)
10.1097/AOG.0b013e3181985312
Symptomatic Pelvic Organ Prolapse at Midlife, Quality of Life, and Risk Factors
X. Fritel (2009)
10.1200/JCO.2009.24.9284
Breast cancer subtypes and the risk of local and regional relapse.
K. D. Voduc (2010)
10.1080/000164700317381234
Effects of basic fibroblast growth factor (bFGF) on early stages of tendon healing: A rat patellar tendon model
B. Chan (2000)
10.1016/S1470-2045(10)70008-5
Breast cancer molecular profiling with single sample predictors: a retrospective analysis.
B. Weigelt (2010)
10.1007/s00192-005-1294-5
Uterosacral ligament in postmenopausal women with or without pelvic organ prolapse
B. Gabriel (2005)
10.2165/00007256-200333050-00004
The Roles of Growth Factors in Tendon and Ligament Healing
T. Molloy (2003)
10.1002/gcc.20646
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype?
R. Natrajan (2009)
Comparative genomic hybridization of breast tumors stratified by histological grade reveals new insights into the biological progression of breast cancer.
R. Roylance (1999)
10.1186/bcr2635
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
A. Prat (2010)
10.1159/000331339
Invasive Breast Cancer: Recognition of Molecular Subtypes
J. Strehl (2011)
10.1038/35102167
Stem cells, cancer, and cancer stem cells
T. Reya (2001)
10.1097/01.AOG.0000182584.15087.dd
Remodeling of Vaginal Connective Tissue in Patients With Prolapse
P. Moalli (2006)
10.1093/HUMREP/DEG420
Changes in extracellular matrix proteins in the cardinal ligaments of post-menopausal women with or without prolapse: a computerized immunohistomorphometric analysis.
A. Ewies (2003)
10.1038/sj.onc.1208561
Identification of molecular apocrine breast tumours by microarray analysis
P. Farmer (2005)
10.1093/jnci/djp082
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
M. Cheang (2009)
10.1016/S0140-6736(96)91489-0
Changes in metabolism of collagen in genitourinary prolapse
S. Jackson (1996)
10.1186/1471-2407-11-334
Involvement of Cox-2 in the metastatic potential of chemotherapy-resistant breast cancer cells
Ju-Hee Kang (2011)
10.1016/J.EJCA.2004.08.021
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities.
T. Sørlie (2004)
10.1200/JCO.2006.07.0250
Prognostic significance of human epidermal growth factor receptor positivity for the development of brain metastasis after newly diagnosed breast cancer.
Z. Gabos (2006)
10.4161/cbt.10.10.13879
Histological, molecular and functional subtypes of breast cancers
G. Malhotra (2010)
Molecular characterization of apoptosis by the immunohistochemical evaluation of Bcl-2 in breast cancer.
D. Zaha (2012)
10.1158/1078-0432.CCR-04-0220
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
T. Nielsen (2004)
10.3109/13697137.2010.500010
Uterine prolapse: evaluation of glycosaminoglycans in postmenopausal women after estrogen therapy
J. C. Nunes (2011)
10.1111/j.1471-0528.2007.01606.x
Vaginal surgery for pelvic organ prolapse using mesh and a vaginal support device
M. Carey (2008)
10.1080/07357900701784238
Molecular Subtypes in Breast Cancer Evaluation and Management: Divide and Conquer
J. Peppercorn (2008)
10.1016/j.acthis.2010.02.001
Changes of glycoprotein and collagen immunolocalization in the uterine artery wall of postmenopausal women with and without pelvic organ prolapse.
C. Goepel (2011)
10.1158/1078-0432.CCR-10-1282
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
T. Nielsen (2010)
10.1158/1078-0432.CCR-10-0752
p27: A Barometer of Signaling Deregulation and Potential Predictor of Response to Targeted Therapies
S. Wander (2010)
10.1002/nau.20972
Neuromuscular morphometry of the uterine ligaments and vaginal wall in women with pelvic organ prolapse
Petek Balkanlı Kaplan (2011)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar